Envoy Medical, Inc. 8-K

What Happened
Envoy Medical, Inc. announced its financial results for the fourth fiscal quarter and fiscal year ended December 31, 2025 in a press release dated March 23, 2026. The company filed an 8-K on March 27, 2026 (Item 2.02) to furnish that press release and made the related data available as an Inline XBRL exhibit.

Key Details

• Press release dated March 23, 2026 reporting Q4 and fiscal year 2025 results is attached as Exhibit 99.1 to the 8-K.
• The 8-K was filed on March 27, 2026 and cites Item 2.02 (Results of Operations and Financial Condition).
• The filing includes an Inline XBRL interactive data file as Exhibit 104 for the reported financial data.

Why It Matters
This 8-K notifies investors that Envoy has publicly released its latest earnings and year‑end financial information; investors should review the attached press release and the Inline XBRL exhibit for details on revenue, profitability, cash flow, and any management commentary or forward-looking guidance. Because the 8-K itself primarily furnishes the press release, readers should open Exhibit 99.1 and the XBRL file to see the specific quarterly and annual figures and assess potential impacts on the company’s outlook.